ArticleSurgical neurology international2026
Mortality rates in patients with Parkinson's disease: An analysis of the Global Burden of Disease database.
Article in Surgical neurology international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Parkinson's disease (PD) prevalence is rising globally; however, the implications for mortality remain underexplored. This study evaluates regional PD mortality trends over the past decade. Methods: Age-standardized PD mortality rates from 2011 to 2021 were extracted from the Global Burden of Disease 2021 database for all six World Health Organization regions. Relative changes over time were calculated to assess trends. Results: Mortality trends varied across regions. The Eastern Mediterranean region had the highest mortality in both 2011 (5.48/100,000) and 2021 (5.38/100,000). The Western Pacific Region saw the greatest decline (-5.67%), while the African Region showed minimal improvement (-0.82%). Two regions, the Americas and South-East Asia, experienced net increases. Conclusion: PD mortality improvements are heterogeneous globally, which may reflect differences in access to diagnosis and treatment of PD and comorbidities. Targeted, region-specific strategies should be considered to reduce mortality disparities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.